The US health regulator said on Wednesday that it is working to address a shortage of a particular form of albuterol, a medication used to treat breathing conditions, as its sole manufacturer Akorn has stopped production.
- The U.S. health regulator said on Wednesday that it is working to address a shortage of a particular form of albuterol, a medication used to treat breathing conditions, as its sole manufacturer Akorn has stopped production.
The Food and Drug Administration added that it is working closely with manufacturers in the supply chain to"understand, mitigate and prevent or reduce any related impacts" due to the shortage of the medication. "All other strengths and vial sizes are currently available to meet market demand at hospitals and beyond," the FDA said on Twitter.
The shortage only impacts a very specific dosage form of the medication generally used in hospitals and that it does not impact albuterol inhalers for personal use, according to the regulator.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Nationwide shortage of asthma medication albuterol could worsenAsthma medication albuterol has been facing a shortage since the fall -- and experts say it could get worse after a major supplier closed its facilities.
Weiterlesen »
Old Medication, New Use: Can Prazosin Curb Drinking?Could a blood pressure medication help those with alcohol use disorder? clairewilcoxmd reports on new findings.
Weiterlesen »
Amoxicillin, over the counter medication shortages impacting pharmacies across regionShortages of children's over-the-counter medicines persist, along with frequently prescribed antibiotics like Amoxicillin.
Weiterlesen »
Medication for those with statin intolerance proves effectiveResults from a Cleveland Clinic trial show just how effective a new medication is for individuals who have a statin intolerance.
Weiterlesen »
Doctors file lawsuit against FDA's approval of abortion pillAfter nearly 50 years of federal abortion protections, Roe v. Wade was overturned last summer. And now the fate of mifepristone is the target of a lawsuit filed against the FDA.
Weiterlesen »
Shortages of asthma drug albuterol expected to get worse as supplier closesLiquid albuterol is in short supply, and the shortage is only expected to get worse.
Weiterlesen »